GeneDx Holdings (WGS) EBT Margin Growth (3y) (2023 - 2026)
GeneDx Holdings (WGS) EBT Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 266.00 |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -211.00 |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 3,356.00 |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 28.00 |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -317.00 |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 399.00 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 3,000.00 |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 135.00 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 360.00 |
| 10 | GeneDx Holdings | 2.65 Bn | 2.52 Bn | 78.24 Mn | 8,037.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8,037.00 |
| Mar 31, 2026 | 8,068.00 |
| Dec 31, 2025 | 48,806.00 |
| Sep 30, 2025 | 8,696.00 |
| Jun 30, 2025 | 38,303.00 |
| Mar 31, 2025 | 13,557.00 |
| Dec 31, 2024 | 7,518.00 |
| Sep 30, 2024 | -8,668.00 |
| Jun 30, 2024 | 5,654.00 |
| Mar 31, 2024 | 26,616.00 |
| Dec 31, 2023 | 1,680.00 |
| Sep 30, 2023 | 6,699.00 |
| Jun 30, 2023 | 1,716.00 |
| Mar 31, 2023 | -8,434.00 |